Ex-Amgen CEO to would-be leaders: Focus on behavior, not abilities

If you could bring in former Amgen ($AMGN) CEO Kevin Sharer as a consultant, what would he say? Don't hire consultants--at least not when your top executives are codifying the sorts of behaviors they want to see in company leaders. Report

Suggested Articles

Download our solutions overview to discover how CoverMyMeds can make a difference for your brand.

In a bladder cancer field chock-full of checkpoint inhibitors, Pfizer and Merck KGaA’s Bavencio has a chance to get ahead thanks to new data.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.